• 1. Achieving Efficient Uranium Extraction by In-situ Ultrasonic Texturization of Commercial Fe Powder
  BomingZhu,HongweiWu,JieKang,XiaofangYu,TaoChen,RuCheng,GuolinYang,WencaiBai,WenkunZhu,RongHe
• 2. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 3. An antioxidative galactomannan extracted from Chinese Sesbania cannabina enhances immune activation of macrophage cells?
  Chongyang Zhu,Xiaojia Bian,Xin Jia,Ning Tang,Yongqiang Cheng Food Funct., 2020,11, 10635-10644
• 4. Aggregated-fluorescent detection of PFAS with a simple chip
  Cheng Fang,Jinjian Wu,Zahra Sobhani,Md. Al Amin,Youhong Tang Anal. Methods, 2019,11, 163-170
• 5. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977

Recent Advances in the Application of 4-Ethoxypyridine-2-carbaldehyde (CAS: 16665-43-3) in Chemical Biology and Pharmaceutical Research

4-Ethoxypyridine-2-carbaldehyde (CAS: 16665-43-3) has emerged as a versatile building block in chemical biology and pharmaceutical research due to its unique structural features and reactivity. Recent studies have highlighted its potential in the synthesis of novel bioactive compounds, particularly in the development of kinase inhibitors and antimicrobial agents. This research brief aims to provide an overview of the latest advancements in the application of this compound, focusing on its synthetic utility, biological activities, and potential therapeutic applications.

One of the most significant developments in the use of 4-ethoxypyridine-2-carbaldehyde is its role in the synthesis of heterocyclic compounds. Researchers have successfully utilized this aldehyde as a key intermediate in the construction of pyridine-based scaffolds, which are prevalent in many FDA-approved drugs. A recent study published in the Journal of Medicinal Chemistry demonstrated the efficient synthesis of a series of pyrido[2,3-d]pyrimidine derivatives using 4-ethoxypyridine-2-carbaldehyde as a starting material. These derivatives exhibited potent inhibitory activity against several cancer-related kinases, suggesting their potential as anticancer agents.

In addition to its applications in kinase inhibitor development, 4-ethoxypyridine-2-carbaldehyde has shown promise in the design of antimicrobial agents. A 2023 study in Bioorganic & Medicinal Chemistry Letters reported the synthesis of novel Schiff base derivatives from this compound, which displayed significant activity against drug-resistant bacterial strains. The researchers attributed this activity to the compound's ability to disrupt bacterial cell membrane integrity, highlighting its potential as a lead structure for the development of new antibiotics.

The compound's chemical properties have also been explored in material science applications. Recent investigations have demonstrated its utility as a ligand in the synthesis of luminescent metal-organic frameworks (MOFs). These MOFs have shown potential in biosensing applications, particularly in the detection of small molecules relevant to disease biomarkers. The unique electronic properties of the 4-ethoxypyridine moiety contribute to the enhanced sensitivity of these materials.

From a synthetic chemistry perspective, recent methodological advances have improved the efficiency of reactions involving 4-ethoxypyridine-2-carbaldehyde. A 2024 publication in Organic Letters described a novel catalytic system that enables the direct C-H functionalization of this compound under mild conditions, significantly expanding its synthetic utility. This breakthrough has opened new avenues for the rapid construction of complex molecular architectures for drug discovery programs.

Looking forward, the diverse applications of 4-ethoxypyridine-2-carbaldehyde suggest it will continue to play an important role in chemical biology and pharmaceutical research. Current challenges include optimizing its metabolic stability in drug development and exploring its potential in targeted drug delivery systems. Ongoing research efforts are expected to further elucidate the full therapeutic potential of derivatives based on this versatile scaffold.

• 62885-51-2(2-Pyridinecarboxaldehyde, 4,5-dimethoxy-)
• 16744-81-3(4-methoxypyridine-2-carbaldehyde)
• 195967-09-0(Ethanone,1,1'-(4-ethoxy-2,6-pyridinediyl)bis-)
• 443955-90-6(2H,3H-[1,4]dioxino[2,3-c]pyridine-7-carbaldehyde)
• 22187-96-8(5-methoxypyridine-2-carbaldehyde)
• 100063-12-5(6-Ethoxyquinoline-2-carbaldehyde)
• 58402-45-2(7-Ethoxyisoquinoline-1-carbaldehyde)
• 75358-79-1(4-methoxy-6-methylpyridine-2-carbaldehyde)
• 663614-86-6(4-(2-methoxyethoxy)pyridine-2-carboxylic acid)
• 85238-97-7(2,6-Pyridinedicarboxylicacid, 4-ethoxy-)